Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
43.27
-1.64 (-3.65%)
At close: Aug 24, 2026, 4:00 PM EDT
43.25
-0.02 (-0.05%)
After-hours: Aug 24, 2026, 7:56 PM EDT
Definium Therapeutics Market Cap
Definium Therapeutics has a market cap or net worth of $5.81 billion as of August 24, 2026. Its market cap has increased by 649.88% in one year.
Market Cap
5.81B
Enterprise Value
4.77B
1-Year Change
649.88%
Ranking
Category
Stock Price
$43.27
ChartMarket Cap Chart
Since March 4, 2020, Definium Therapeutics's market cap has increased from $595.37M to $5.81B, an increase of 876.55%. That is a compound annual growth rate of 42.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 5.81B | 340.78% |
| Dec 31, 2025 | 1.32B | 158.44% |
| Dec 31, 2024 | 510.39M | 247.80% |
| Dec 29, 2023 | 146.75M | 77.54% |
| Dec 30, 2022 | 82.66M | -85.99% |
| Dec 31, 2021 | 590.17M | -82.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Belite Bio | 6.40B |
| Cogent Biosciences | 6.29B |
| Mirum Pharmaceuticals | 6.28B |
| Dianthus Therapeutics | 6.16B |
| Erasca | 6.16B |
| Travere Therapeutics | 6.15B |
| PTC Therapeutics | 5.93B |
| Xenon Pharmaceuticals | 5.86B |